(Reuters Health) – Aggressive use of crimson-cell transfusion for very-low-initiating-weight newborns with anemia would not toughen survival and fails to stem neurodevelopmental impairment by age…
(Reuters Health) – Aggressive use of crimson-cell transfusion for very-low-initiating-weight newborns with anemia would not toughen survival and fails to stem neurodevelopmental impairment by age…